MedTrace Logo

Efficacy Study of A Lotion to Prevent Common Colds

NCT00993759 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2009-10-12

No results posted yet for this study

Summary

The purpose of this of this study is to determine if 3804-250A can prevent the common cold caused by the rhinovirus when applied to the hands. The study will also evaluate whether 3804-250A can prevent rhinovirus infection or common cold illnesses.

The study will also evaluate the safety of 3804-250A.

Conditions

  • Common Cold
  • Healthy

Interventions

DRUG

3804-250A

3.2 ml applied topically after hand washing and at least every 3 hours while awake.

Sponsors & Collaborators

  • Hill Top Research

    collaborator INDUSTRY

  • The Dial Corporation

    lead INDUSTRY

Principal Investigators

  • Ronald Turner, MD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-11-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00993759 on ClinicalTrials.gov